Literature DB >> 1366962

A nuclear magnetic resonance technique for determining hybridoma cell concentration in hollow fiber bioreactors.

A Mancuso1, E J Fernandez, H W Blanch, D S Clark.   

Abstract

We have developed a technique for determining cell concentration in a hollow fiber bioreactor based on 23Na nuclear magnetic resonance (NMR) spectroscopy. Cell concentrations determined with this method agreed closely with concentrations calculated from 31P NMR nucleoside triphosphate (NTP) measurements and oxygen consumption rate measurements. Oxygen transfer limitations, which can complicate cell mass determinations based on oxygen consumption rates, were shown to be negligible for the bioreactor used. Specific antibody production rates in hollow fiber culture, calculated from these cell number estimates, were similar to those found in suspension culture for this cell line.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1366962     DOI: 10.1038/nbt1290-1282

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  11 in total

1.  Analysis of CHO-K1 cell growth in a fixed bed bioreactor using magnetic resonance spectroscopy and imaging.

Authors:  P E Thelwall; K M Brindle
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

2.  Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor.

Authors:  Kayvan R Keshari; David M Wilson; Mark Van Criekinge; Renuka Sriram; Bertram L Koelsch; Zhen J Wang; Henry F VanBrocklin; Donna M Peehl; Tom O'Brien; Deepak Sampath; Richard A D Carano; John Kurhanewicz
Journal:  Prostate       Date:  2015-07-14       Impact factor: 4.104

3.  Enhanced specific antibody productivity of calcium alginate-entrapped hybridoma is cell line-specific.

Authors:  G M Lee; S J Kim; B O Palsson
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

4.  Mass spectrometry: a tool for on-line monitoring of animal cell cultures.

Authors:  U Behrendt; S Koch; D D Gooch; U Steegmans; M J Comer
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

Review 5.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.

Authors:  Kayvan R Keshari; David M Wilson
Journal:  Chem Soc Rev       Date:  2013-12-20       Impact factor: 54.564

6.  Hyperpolarized (13)C spectroscopy and an NMR-compatible bioreactor system for the investigation of real-time cellular metabolism.

Authors:  Kayvan R Keshari; John Kurhanewicz; Rex E Jeffries; David M Wilson; Brian J Dewar; Mark Van Criekinge; Matthew Zierhut; Daniel B Vigneron; Jeffrey M Macdonald
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

7.  Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.

Authors:  Ralph J DeBerardinis; Anthony Mancuso; Evgueni Daikhin; Ilana Nissim; Marc Yudkoff; Suzanne Wehrli; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-21       Impact factor: 11.205

8.  Effect of oxygen concentration on viability and metabolism in a fluidized-bed bioartificial liver using ³¹P and ¹³C NMR spectroscopy.

Authors:  Rex E Jeffries; Michael P Gamcsik; Kayvan R Keshari; Peter Pediaditakis; Andrey P Tikunov; Gregory B Young; Haakil Lee; Paul B Watkins; Jeffrey M Macdonald
Journal:  Tissue Eng Part C Methods       Date:  2012-09-28       Impact factor: 3.056

9.  Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by 13C NMR Spectroscopy of Perfused Tumor Cells.

Authors:  Alexander A Shestov; Anthony Mancuso; Seung-Cheol Lee; Lili Guo; David S Nelson; Jeffrey C Roman; Pierre-Gilles Henry; Dennis B Leeper; Ian A Blair; Jerry D Glickson
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

10.  (13)C MRS and LC-MS Flux Analysis of Tumor Intermediary Metabolism.

Authors:  Alexander A Shestov; Seung-Cheol Lee; Kavindra Nath; Lili Guo; David S Nelson; Jeffrey C Roman; Dennis B Leeper; Mariusz A Wasik; Ian A Blair; Jerry D Glickson
Journal:  Front Oncol       Date:  2016-06-15       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.